Published 1 month ago • loading... • Updated 1 month ago

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

Sera Prognostics Inc., specializing in maternal and neonatal health diagnostics, is scheduled to participate in the RBC Global Healthcare Conference in Salt Lake City on May 21, 2025.
The presentation follows a PRNewswire announcement on May 14, 2025, confirming the event and CEO Zhenya Lindgardt's participation in a fireside chat providing a company update.
Sera Prognostics develops blood-based pregnancy biomarker tests like PreTRM, which predicts spontaneous preterm birth risk during weeks 18 to 20 of pregnancy to assist personalized clinical decisions.
Preterm birth, defined as birth before 37 weeks, affects over one in ten infants annually in the U.S. and contributes to $25 billion in healthcare costs due to related long-term complications.
Sera Prognostics aims to improve maternal and newborn health while reducing healthcare costs through innovative diagnostics, with the upcoming presentation highlighting its recent progress and future plans.

Insights by Ground AI

Does this summary seem wrong?

27 Articles

All

Left

Center

Right

Montana Standard

+26 Reposted by 26 other sources

Center

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

SALT LAKE CITY , May 14, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will…

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year